![Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3621/MediaObjects/13058_2014_3378_Fig1_HTML.jpg)
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
![Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2c4ed38b-36d5-464d-9b64-c8ff5bff5ac2/gr1.jpg)
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer
![Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3939bb25-73dd-487a-8490-1dae0e8d6902/gr1.jpg)
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology
![Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt.12.35/asset/images/medium/figure1.gif)
Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management
![SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy](https://minio.scielo.br/documentstore/1678-2690/VmpSNGmgJfQmKMWx9fxmzWP/cb4a5f7022067b7ce664581cd539d9f1d770eb31.png)
SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy
![IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-17-02095/article_deploy/html/images/ijms-17-02095-g005.png)
IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML
![Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/figure2-mechanism-of-action.png)
Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology
![Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review) Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)](https://www.spandidos-publications.com/article_images/etm/16/3/etm-16-03-2183-g00.jpg)
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
![Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/c6df350ca596a30931323c692e602c7c6a33d06f-498x387.gif)
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
![Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.13.7/asset/images/medium/figure1.gif)
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology
![Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram](https://www.researchgate.net/publication/267932500/figure/fig1/AS:601626331058214@1520450303996/Structure-of-trastuzumab-emtansine-and-mechanisms-of-action-Notes-On-binding-of.png)
Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram
![Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram](https://www.researchgate.net/profile/Anne-Sophie-Hervent/publication/233829203/figure/fig2/AS:300028787740675@1448543845517/Mode-action-of-current-ErbB2-inhibitors-Trastuzumab-pertuzumab-and-lapatinib-have-a.png)